These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2029988)

  • 1. HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B.
    Paul RG; Roodman ST; Campbell CR; Bodicky CJ; Perrillo RP
    Hepatology; 1991 May; 13(5):820-5. PubMed ID: 2029988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon.
    Freni MA; Ajello A; Spadaro A; Fava A; Calapristi I; Marafioti T; Alessi N; Resta ML; Ferraù O
    Hepatogastroenterology; 1997; 44(17):1295-301. PubMed ID: 9356842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C.
    Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K
    Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
    García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R
    Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interferon-alpha treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C.
    Piazzolla G; Giannelli G; Antonelli G; Tortorella C; Jirillo E; Schiraldi O; Antonaci S
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):529-48. PubMed ID: 8933168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
    Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver HLA-G expression is associated with multiple clinical and histopathological forms of chronic hepatitis B virus infection.
    Souto FJ; Crispim JC; Ferreira SC; da Silva AS; Bassi CL; Soares CP; Zucoloto S; Rouas-Freiss N; Moreau P; Martinelli AL; Donadi EA
    J Viral Hepat; 2011 Feb; 18(2):102-5. PubMed ID: 20236238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of human leukocyte antigen class I genes by interferon in vivo and in vitro.
    Schmidt H; Kellermann-Kegreiss E; Steiert I; Walz J; Zinser R; Müller CA
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):169-74. PubMed ID: 7507709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
    Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
    Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.
    Leung NW; Leung JC; Tam JS; Lau JT; Lai KN
    Am J Gastroenterol; 1992 Jan; 87(1):113-7. PubMed ID: 1728107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic viral hepatitis type B with oral mucosal administration of natural human interferon alpha lozenges.
    Caban J; Mossor-Ostrowska J; Zyrkowska-Bieda T; Zejc M; Janas-Skulina U; Cieśla A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):229-35. PubMed ID: 8129566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
    Akhan SC; Yulugkural Z; Vahaboglu H
    Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.